A tailored course, built for your situation
Board-Level AI in Pharmaceutical R&D Operations for Regulated Industries
Master governance, compliance, and strategic implementation of AI in drug development
$199 one-time
24-hour access provisioning
30-day money-back guarantee
Hand-built implementation playbook
12 modules. 12 chapters per module. 144 chapters total.
12 modules, each with 12 chapters (144 chapters total), text-based, plus downloadable templates and a hand-built implementation playbook delivered alongside course access.
AI promises transformation in pharma R&D, but without board-aligned governance, even the most advanced models stall at validation or fail regulatory scrutiny.
The situation this course is for
Professionals in regulated pharma environments face mounting pressure to deliver AI-driven innovation while maintaining compliance with evolving standards. The gap between technical capability and governance readiness creates delays, rework, and missed opportunities for strategic impact.
Who this is for
Compliance officers, R&D leaders, data governance professionals, and technology strategists in pharmaceutical and life sciences organizations operating under FDA, EMA, or other regulatory frameworks.
Who this is not for
This course is not for software developers seeking coding tutorials or data scientists focused solely on model architecture. It is not an introductory AI course, nor is it designed for unregulated industries.
What you walk away with
- Align AI initiatives with board-level risk and compliance expectations
- Design audit-ready AI workflows compliant with GxP and 21 CFR Part 11
- Lead cross-functional teams through AI validation in regulated environments
- Anticipate regulatory feedback loops in AI-augmented drug development
- Build scalable governance frameworks for AI deployment in clinical and preclinical research
The 12 modules (with all 144 chapters)
Module 1. AI Governance in Regulated Pharmaceutical Environments
Establish foundational governance principles aligned with board-level expectations and regulatory standards.
12 chapters in this module
- Defining AI governance in pharma
- Regulatory landscape overview
- Board oversight models
- Risk appetite frameworks
- Cross-functional governance teams
- Policy development lifecycle
- Audit trail requirements
- Change control integration
- Document retention standards
- Stakeholder communication plans
- Escalation protocols
- Governance maturity assessment
Module 2. Regulatory Frameworks for AI in Drug Development
Navigate current compliance requirements across FDA, EMA, ICH, and other global bodies.
12 chapters in this module
- 21 CFR Part 11 compliance for AI
- GxP implications for machine learning
- ICH Q9 quality risk management
- EMA AI reflection paper guidelines
- Data integrity in AI systems
- Validation of AI-driven decisions
- Submission documentation standards
- Inspection readiness protocols
- Global regulatory alignment
- Labeling AI-supported outcomes
- Post-market surveillance integration
- Regulatory intelligence workflows
Module 3. AI Strategy Alignment with R&D Objectives
Connect AI initiatives to pipeline goals, resource planning, and innovation KPIs.
12 chapters in this module
- Strategic AI prioritization
- R&D pipeline mapping
- Resource allocation models
- Innovation portfolio management
- Cross-divisional alignment
- Budgeting for AI initiatives
- Technology roadmap integration
- Vendor selection criteria
- IP considerations for AI models
- Stage-gate integration
- Performance benchmarking
- Value realization tracking
Module 4. Data Governance for AI in Clinical Research
Ensure data quality, provenance, and compliance across clinical trial datasets.
12 chapters in this module
- Clinical data standards (CDISC)
- Patient data anonymization
- Source data verification
- Data lineage tracking
- Master data management
- Data access controls
- Consent management systems
- Data quality metrics
- Interoperability frameworks
- Real-world data integration
- Data stewardship roles
- Data governance audits
Module 5. AI Model Validation in Regulated Settings
Implement validation protocols that meet regulatory scrutiny and scientific rigor.
12 chapters in this module
- Validation lifecycle planning
- Test case development
- Performance benchmarking
- Bias and fairness assessment
- Model interpretability
- Sensitivity analysis
- Version control procedures
- Retraining validation
- Failure mode analysis
- Peer review integration
- Documentation standards
- Validation sign-off workflows
Module 6. Change Management for AI Adoption
Lead organizational change with structured communication and training frameworks.
12 chapters in this module
- Stakeholder impact analysis
- Resistance mitigation strategies
- Training program design
- Communication cadence planning
- Role transition support
- Feedback loop integration
- Adoption metrics tracking
- Knowledge transfer protocols
- Leadership alignment workshops
- Culture change indicators
- Post-implementation review
- Continuous improvement models
Module 7. AI in Drug Discovery and Preclinical Research
Apply AI to target identification, compound screening, and toxicity prediction.
12 chapters in this module
- Target identification with AI
- Virtual screening workflows
- Structure-activity modeling
- Toxicity prediction models
- ADMET prediction accuracy
- Generative chemistry applications
- High-throughput data integration
- Lab automation interfaces
- Data standardization needs
- Validation in preclinical context
- IP landscape analysis
- Collaboration with CROs
Module 8. AI in Clinical Trial Design and Optimization
Enhance trial efficiency through predictive enrollment, site selection, and protocol design.
12 chapters in this module
- Predictive enrollment modeling
- Site selection optimization
- Protocol feasibility analysis
- Patient stratification models
- Risk-based monitoring
- Adaptive trial design
- Endpoint prediction
- Real-world evidence integration
- Trial simulation tools
- Regulatory submission alignment
- Patient recruitment forecasting
- Decentralized trial support
Module 9. AI for Regulatory Submissions and Compliance
Streamline dossier preparation, review, and response processes with AI support.
12 chapters in this module
- Automated document generation
- Regulatory intelligence tools
- Submission readiness checks
- Response drafting assistance
- Comment tracking systems
- Cross-referencing accuracy
- Language consistency validation
- Format compliance checks
- Version control for submissions
- Collaboration with regulatory affairs
- Audit trail integration
- Post-submission follow-up
Module 10. Risk Management for AI-Driven Decisions
Apply structured risk assessment to AI outputs influencing clinical and regulatory outcomes.
12 chapters in this module
- Risk identification frameworks
- Hazard analysis techniques
- Failure mode assessment
- Residual risk evaluation
- Control measure design
- Risk communication plans
- Independent review processes
- Escalation pathways
- Risk documentation standards
- Periodic reassessment
- Third-party audit preparation
- Regulatory inspection response
Module 11. AI Ethics and Patient Safety in Pharma
Ensure ethical deployment with patient safety as the central principle.
12 chapters in this module
- Ethical AI principles
- Bias detection in health data
- Equity in trial participation
- Transparency requirements
- Explainability standards
- Patient impact assessment
- Informed consent considerations
- Oversight committee design
- Whistleblower protection
- Incident response protocols
- Public trust maintenance
- Ethics training programs
Module 12. Scaling AI Across the Pharmaceutical Enterprise
Expand AI capabilities from pilot to enterprise-wide deployment with governance intact.
12 chapters in this module
- Enterprise architecture integration
- Platform standardization
- Centralized model repository
- Governance at scale
- Cross-project coordination
- Resource sharing models
- Knowledge management systems
- Performance monitoring
- Compliance automation
- Vendor ecosystem management
- Continuous validation
- Strategic review cadence
How this maps to your situation
- Aligning AI with board-level risk appetite
- Navigating regulatory submissions with AI support
- Validating models under GxP and 21 CFR Part 11
- Scaling AI across R&D while maintaining compliance
Before vs. after
Before
Uncertainty about how to align AI initiatives with regulatory expectations and board oversight, leading to stalled projects and compliance risk.
After
Confidence in deploying AI within validated, audit-ready frameworks that meet both strategic and regulatory demands.
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 45, 60 hours total, designed for flexible, self-paced learning with implementation milestones.
If nothing changes
Without structured governance, AI initiatives in pharma R&D risk non-compliance, failed audits, and loss of stakeholder trust, even when technically successful.
How this compares to the alternatives
Unlike generic AI courses, this program is built specifically for regulated pharma R&D, with compliance-grade detail, audit-ready templates, and board-level governance frameworks not found in academic or technical training.
Frequently asked
Who is this course designed for?
Compliance officers, R&D leaders, data governance professionals, and technology strategists in pharmaceutical and life sciences organizations operating under FDA, EMA, or other regulatory frameworks.
How is the course structured?
12 modules, each containing 12 chapters (144 chapters total).
Is this course technical or strategic?
It bridges both, providing strategic governance frameworks and implementation-grade practices for regulated environments.
$199 one-time. Approximately 45, 60 hours total, designed for flexible, self-paced learning with implementation milestones..
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.
30-day money-back guarantee·
144 chapters·
Hand-built playbook included·
Account access within 24 hours